• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Stem Cell Reports . Conjunctival epithelial cells resist productive SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Stem Cell Reports


. 2022 Jun 3;S2213-6711(22)00270-3.
doi: 10.1016/j.stemcr.2022.05.017. Online ahead of print.
Conjunctival epithelial cells resist productive SARS-CoV-2 infection


Robert M Jackson[SUP] 1 [/SUP], Catherine F Hatton[SUP] 2 [/SUP], Jarmila Stremenova Spegarova[SUP] 2 [/SUP], Maria Georgiou[SUP] 1 [/SUP], Joseph Collin[SUP] 1 [/SUP], Emily Stephenson[SUP] 1 [/SUP], Bernard Verdon[SUP] 1 [/SUP], Iram J Haq[SUP] 2 [/SUP], Rafiqul Hussain[SUP] 1 [/SUP], Jonathan M Coxhead[SUP] 1 [/SUP], Hardeep-Singh Mudhar[SUP] 3 [/SUP], Bart Wagner[SUP] 4 [/SUP], Megan Hasoon[SUP] 1 [/SUP], Tracey Davey[SUP] 4 [/SUP], Paul Rooney[SUP] 5 [/SUP], C M Anjam Khan[SUP] 1 [/SUP], Chris Ward[SUP] 1 [/SUP], Malcolm Brodlie[SUP] 2 [/SUP], Muzlifah Haniffa[SUP] 6 [/SUP], Sophie Hambleton[SUP] 2 [/SUP], Lyle Armstrong[SUP] 1 [/SUP], Francisco Figueiredo[SUP] 7 [/SUP], Rachel Queen[SUP] 8 [/SUP], Christopher J A Duncan[SUP] 9 [/SUP], Majlinda Lako[SUP] 10 [/SUP]



Affiliations
Free PMC article

Abstract

Conjunctival epithelial cells, which express viral-entry receptors angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine type 2 (TMPRSS2), constitute the largest exposed epithelium of the ocular surface tissue and may represent a relevant viral-entry route. To address this question, we generated an organotypic air-liquid-interface model of conjunctival epithelium, composed of basal, suprabasal, and superficial epithelial cells, and fibroblasts, which could be maintained successfully up to day 75 of differentiation. Using single-cell RNA sequencing (RNA-seq), with complementary imaging and virological assays, we observed that while all conjunctival cell types were permissive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome expression, a productive infection did not ensue. The early innate immune response to SARS-CoV-2 infection in conjunctival cells was characterised by a robust autocrine and paracrine NF-κB activity, without activation of antiviral interferon signalling. Collectively, these data enrich our understanding of SARS-CoV-2 infection at the human ocular surface, with potential implications for the design of preventive strategies and conjunctival transplantation.

Keywords: ACE2; IFN; NFKB; SARS-CoV-2; TMPRSS2; conjunctiva; conjunctival epithelium; ocular surface; productive infection.
 
Back
Top Bottom